Medical treatments are already personalised, in that patients are assessed before a suitable treatment is selected for them. But did you know that a large portion of treatments are ineffective being applied to the wrong community of patients? Or that conventional drug therapies currently in use do not take into account individual genetic variations and differences in response to drugs?
Content
COST (European Cooperation in Science and Technology) is one of the longest-running European instruments supporting cooperation among scientists and researchers across Europe. read more
Open Call
The next collection date is 24 September 2010, 17:00 Brussels time
Quick Access
Quick Access Menu
- Biomedicine and Molecular Biosciences
- Chemistry and Molecular Sciences and Technology
-
Food and Agriculture - Earth System Science and Environmental Management
- Forests, their Products and Services
- Individuals, Societies, Cultures and Health
- Information and Communication Technologies
- Materials, Physical and Nanosciences
- Transport and Urban Development
President's Corner
Soon this section will feature Dr Ángeles Rodríguez Peña, President of the COST Committee of Senior Officials since 22 June 2010. read more